Navigation Links
New clinical trial to test novel approach to treat triple-negative breast cancer
Date:6/2/2011

motherapy is currently the only drug treatment option, and it has a lot of side effects compared to hormone therapies like anastrozole."

Triple-negative breast cancer is unique in that it lacks three common receptors in the cell estrogen, progesterone or human epidermal growth factor 2 (HER2), which are the targets of drugs widely used today to treat breast cancer. As a result, this cancer can be very difficult to treat; it doesn't respond to therapies that target estrogen and progesterone receptors, such as tamoxifen (Nolvadex), fulvestrant (Faslodex) and aromatase inhibitors (Femara, Arimidex and Aromasin), or to HER2-targeted therapies such as trastuzumab (Herceptin) and lapatinib (Tykerb).

About 15 to 20 percent of breast cancers are triple-negative. For unknown reasons, there is a higher prevalence of this type of breast cancer among African-Americans, young women and women with the BRCA1 gene mutation. African-American women are twice as likely as white women to have this type of cancer, which can be very aggressive and spread to other parts of the body, such as the lungs, liver and brain.

The clinical trial is based on laboratory studies by Dr. Brodie, a professor of pharmacology and experimental therapeutics, and Gauri J. Sabnis, Ph.D., an assistant professor of pharmacology and experimental therapeutics, at the University of Maryland School of Medicine, in collaboration with Saraswati Sukumar, M.S., Ph.D., a professor of oncology and pathology at the Johns Hopkins University School of Medicine. Their research showed that entinostat can sensitize triple-negative breast cancer cells to treatment with an aromatase inhibitor, and when combined with an aromatase inhibitor, also reduce the growth and spread of tumors in animal models.

"Adding to her long list of remarkable achievements, Dr. Brodie has continued her research into aromatase inhibitors, searching for ways to overcome tumors' resistance to treatment," says E. Alb
'/>"/>

Contact: Karen E. Warmkessel
kwarmkessel@umm.edu
410-328-8919
University of Maryland Medical Center
Source:Eurekalert  

Page: 1 2 3

Related biology news :

1. The use of placebo in rheumatoid arthritis clinical trials may negatively impact patients
2. Clinical study suggests estrogen levels and breast health can be altered
3. Progress toward the clinical application of autologous induced pluripotent stem cells and gene repair therapy for treatment of familial hypercholesterolemia
4. New cancer drug discovered at U-M heads to clinical trials
5. JAMIA: Evaluating clinical information systems, patients who use PHRs, how clinicians use EHRs
6. Preview of oral presentations at the 1st IOF-ESCEO Pre-Clinical Symposium
7. Press registration open for clinical nutrition conference
8. Clinical Benefits of Zimmers DeNovo® NT Natural Tissue Graft in First Surgery Documented in Peer-Reviewed Publication
9. Media alert: ACMG 2011 Clinical Genetics Meeting -- press registration is now open
10. MedNet Solutions Announces Significant Enhancements to ENLIGHTEN, Its Flagship EDC / eClinical Solution
11. UTHealth, Athersys preclinical research on stem cell therapy for stroke presented at AHA conference
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
New clinical trial to test novel approach to treat triple-negative breast cancer
(Date:6/24/2015)... JOSE, Calif. , June 24, 2015 /PRNewswire/ ... developer of human interface solutions, today announced that ... sensor to provide secure authentication for its latest ... recently reached more than 200 million shipments of ... with Sharp reinforces Synaptics, strength, scalability and leadership ...
(Date:6/23/2015)... RALEIGH, N.C. , June 23, 2015 /PRNewswire/ ... technology, today announced the results of a recent ... unmatched accuracy on the wrist during activity. In ... biometric technology was compared along with the Apple ... for accurately measuring heart rate during activity. The ...
(Date:6/17/2015)... , and HILDEN, Germany , June 17, ... ; Frankfurt Prime Standard: QIA) today launched new Investigator ® ... forensic laboratories in the United States . ... simultaneously analyze multiple key genomic markers (short tandem repeats or ... Quality Sensor to evaluate the quality of DNA in each ...
Breaking Biology News(10 mins):Synaptics Brings Natural ID Technology to Sharp's Newest Flagship Smartphone 2Valencell Delivers Breakthrough Heart Rate Accuracy on the Wrist 2Valencell Delivers Breakthrough Heart Rate Accuracy on the Wrist 3QIAGEN Launches New Genetic Fingerprinting Kits for U.S. Forensic Labs 2QIAGEN Launches New Genetic Fingerprinting Kits for U.S. Forensic Labs 3QIAGEN Launches New Genetic Fingerprinting Kits for U.S. Forensic Labs 4QIAGEN Launches New Genetic Fingerprinting Kits for U.S. Forensic Labs 5
... NASA,s space shuttle Discovery will make its swan song ... Boulder-built biomedical payload devices, including one to help scientists ... in the low gravity of space as a way ... The experiments will be carried aboard Discovery in sets ...
... Washington, DC (October 27, 2010) Recognizing the ... Collegiate Inventors Competition, a program of Invent Now, today ... in mice to facilitate drug testing and a way ... in this year,s competition. Alice Chen of the ...
... Move over, touchpad screens: New research funded in part ... possible to manipulate complex visual images on a computer screen ... Nature , found that when research subjects had their brains ... force the computer to display one of the images and ...
Cached Biology News:Swan song of space shuttle Discovery to carry 2 payloads built by CU-Boulder 2Swan song of space shuttle Discovery to carry 2 payloads built by CU-Boulder 3Winners announced in 2010 Collegiate Inventors Competition 2Winners announced in 2010 Collegiate Inventors Competition 3Winners announced in 2010 Collegiate Inventors Competition 4Winners announced in 2010 Collegiate Inventors Competition 5From touchpad to thought-pad? 2From touchpad to thought-pad? 3
(Date:7/7/2015)... , July 7, 2015 ... Gene Therapy Market Analysis" report is an essential ... therapy field. Using detailed company data, deal analysis, ... an in-depth analysis of the current and future ... report discusses the key factors shaping and driving ...
(Date:7/7/2015)... , ... July 07, 2015 , ... 4MD Medical ... Women’s Association, offering an exclusive scholarship opportunity for women across the country to earn ... individual as they continue their education,” said Rochelle Schwartz, Founder of 4MD Medical and ...
(Date:7/7/2015)... DEARBORN, Mich. , July 7, 2015  SME,s ... for its third-annual "30 Under 30" issue, celebrating young ... in manufacturing. The July issue of ... young manufacturing professionals and students for their accomplishments. Among ... with the U.S. Air Force on optimizing the topology ...
(Date:7/7/2015)... ... July 07, 2015 , ... Since ... the biometrical area. What began as a conference for European Statistical Programmers, has ... functions in the biometrical area. Statistical Programmers, Data Managers and Biostatisticians all over ...
Breaking Biology Technology:PharmaSphere: Emerging Biotechnologies - Gene Therapy Market Analysis 24MD Medical Announces $2,000 Scholarship Opportunity in Conjunction with American Business Women’s Association (ABWA) 24MD Medical Announces $2,000 Scholarship Opportunity in Conjunction with American Business Women’s Association (ABWA) 3SME's Advanced Manufacturing Media Recognizes "30 Under 30" Future Leaders of Manufacturing 2SME's Advanced Manufacturing Media Recognizes "30 Under 30" Future Leaders of Manufacturing 3SME's Advanced Manufacturing Media Recognizes "30 Under 30" Future Leaders of Manufacturing 4SME's Advanced Manufacturing Media Recognizes "30 Under 30" Future Leaders of Manufacturing 5PhUSE Delighted to Welcome Member Number 5.000 2
... (Nasdaq: EXEL ) announced today that George A. ... present at,the 19th Annual Piper Jaffray Health Care Conference ... November 27, 2007., The presentation will be webcast ... Investors on the Exelixis website at, http://www.exelixis.com ., ...
... findings published in November 22 issue of Nature ... first system-wide gene-analysis of microbial community focused ... Nov. 21 Verenium,Corporation (Nasdaq: VRNM ), ... and a pioneer in the development of,high-performance specialty ...
... SGX Pharmaceuticals, Inc.,(Nasdaq: SGXP ) announced today that ... which Mike Grey, president & chief,executive officer of SGX Pharmaceuticals, ... information is as follows:, -- 19th Annual Piper ... November 27, 2007 at 11:30 AM Eastern Standard Time at ...
Cached Biology Technology:Verenium Explores Bacterial Genes Inside Termite Guts to Understand How Wood is Broken Down and Converted to Energy 2Verenium Explores Bacterial Genes Inside Termite Guts to Understand How Wood is Broken Down and Converted to Energy 3Verenium Explores Bacterial Genes Inside Termite Guts to Understand How Wood is Broken Down and Converted to Energy 4Verenium Explores Bacterial Genes Inside Termite Guts to Understand How Wood is Broken Down and Converted to Energy 5SGX Pharmaceuticals to Present at Two Upcoming Investor Conferences 2
... Antibody, Unconjugated Applications: ... dilution of 1/100. IP: Use at ... at an assay dependent dilution. Predicted ... in other applications. Optimal dilutions/concentrations ...
Kit containing MACS equipment and reagents for immunopurification of proteins....
Membrane Proteins from over 50 different human Alzheimer, Diabetic, Liver Cirrhosis, and Lupus diseased tissues are available....
... Successful biomarker discovery projects require ... samples to distinguish clinically relevant data ... CiphergenExpress Data Manager is now available ... sample tracking and data flood inherent ...
Biology Products: